Korro Bio, Inc.
KRRONasdaqCIK 1703647HealthcareFiscal year ends Dec 31
Reports and events: 142 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2024-04-2419:33 ET | SC 13D/A | Ownership report, active investor, amended | 0001072613-24-000402 |
| 2024-04-2217:09 ET | 8-K | 8.01 Other events | 0001193125-24-105037 |
| 2024-04-1808:40 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-100069 |
| 2024-03-2616:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-077613 |
| 2024-03-2616:02 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-036396 |
| 2024-01-0909:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-004911 |
| 2023-12-2016:44 ET | S-1/A | Registration statement, amended | 0001193125-23-299978 |
| 2023-12-0116:07 ET | S-1/A | Registration statement, amended | 0001193125-23-287451 |
| 2023-11-2916:01 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-23-285164 |
| 2023-11-1712:38 ET | SC 13D | Ownership report, active investor | 0001072613-23-000581 |
| 2023-11-1416:31 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-23-277147 |
| 2023-11-1316:15 ET | SC 13D | Ownership report, active investor | 0001104659-23-117226 |
| 2023-11-0608:51 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 2.02 Results of operations; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 4.01 Change of auditor; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.05 Item not in the standard list; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 8.01 Other events | 0001193125-23-270898 |
| 2023-11-0216:05 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000950170-23-058171 |
| 2023-09-2716:05 ET | 8-K | 1.02 Termination of a material agreement; 8.01 Other events | 0001193125-23-243671 |
| 2023-08-1516:05 ET | 8-K | 1.02 Termination of a material agreement | 0001193125-23-213436 |
| 2023-08-1016:06 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0000950170-23-041300 |
| 2023-08-1016:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-041285 |
| 2023-07-3116:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-23-199108 |
| 2023-07-1416:52 ET | 8-K | 1.01 Entry into a material agreement; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-23-187318 |
| 2023-07-1406:41 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-186853 |
| 2023-06-0616:05 ET | 8-K | 2.05 Exit or disposal costs; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-23-161600 |
| 2023-05-1216:06 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0000950170-23-021755 |
| 2023-05-1216:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-021752 |
| 2023-05-1016:06 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-23-140700 |
| 2023-05-0116:16 ET | 10-K/A | Annual report, amendedPeriod 2022-12-31 | 0001193125-23-130462 |
| 2023-03-2916:05 ET | 8-K | 3.01 Delisting notice; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-23-083653 |
| 2023-03-1007:41 ET | 10-K | Annual reportPeriod 2022-12-31 | 0000950170-23-007140 |
| 2023-03-1007:35 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-007138 |
| 2023-02-1308:15 ET | 8-K | 2.02 Results of operations; 2.05 Exit or disposal costs; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-034390 |
| 2022-12-1307:31 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-22-303234 |
| 2022-11-0816:16 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0000950170-22-023231 |
| 2022-11-0816:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-22-023217 |
| 2022-09-1216:06 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-22-242861 |
| 2022-08-0916:17 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0000950170-22-016072 |
| 2022-08-0916:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-22-016055 |
| 2022-07-1216:35 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-22-192035 |
| 2022-06-2316:31 ET | 8-K | 5.07 Shareholder vote results | 0001193125-22-180199 |
| 2022-05-0416:45 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0000950170-22-007423 |
| 2022-05-0416:41 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-22-007420 |
| 2022-04-2916:32 ET | DEF 14A | Proxy statementPeriod 2022-06-21 | 0001193125-22-133971 |
| 2022-04-1516:31 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-22-106844 |
| 2022-04-0817:15 ET | 8-K | 2.05 Exit or disposal costs; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-22-100522 |
| 2022-03-3117:16 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-22-092065 |
| 2022-03-1817:01 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-079591 |
| 2022-03-1507:42 ET | 10-K | Annual reportPeriod 2021-12-31 | 0000950170-22-003655 |
| 2022-03-1507:35 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-22-003653 |
| 2022-01-1307:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-22-008133 |
| 2021-12-1016:07 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-21-353939 |
| 2021-12-0907:31 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-21-352113 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 23:34 ET. Listed shows no prices and gives no investment advice.